Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04485559
Title Trametinib and Everolimus for the Treatment of Pediatric and Young Adult Patients With Recurrent Low Grade Gliomas (PNOC021)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, San Francisco
Indications

high grade glioma

Therapies

Everolimus + Trametinib

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.